Post-IPO Equity - KalVista Pharmaceuticals - Dec 27, 2022 Funding Round Profile - Cointime

Bitcoin $88,948.05 -3.71%
Ethereum $3,143.67 -4.27%
BNB $633.08 +0.11%
Optimism $1.59 -4.82%
Arbitrum $0.60 -5.55%
Solana $215.31 -1.70%
Polygon $0.36 -7.14%
Cosmos $5.00 -5.69%
Avalanche $32.44 -5.55%

Bitcoin $88,948.05 -3.71%
Ethereum $3,143.67 -4.27%
BNB $633.08 +0.11%
Optimism $1.59 -4.82%
Arbitrum $0.60 -5.55%
Solana $215.31 -1.70%
Polygon $0.36 -7.14%
Cosmos $5.00 -5.69%
Avalanche $32.44 -5.55%

KalVista Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 58M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 23, 2011	Series A	£ 8M	Novo Holdings,SV Health Investors	Detail
Feb 10, 2021	Post-IPO Equity	$ 193.50M		Detail
Jul 22, 2015	Series B	$ 33M	Longwood Fund,Novo Holdings,etc.	Detail
Sep 6, 2015	IPO	$ 68M		Detail